The stock price of APR, expected to improve its performance due to strong sales in North America, is on the rise.
As of 9:37 AM on the 5th, APR was trading at 53,800 KRW, up 2,700 KRW (5.28%) from the previous trading day.
On this day, Daol Investment & Securities maintained a buy rating and a target price of 80,000 KRW for APR, stating, "Considering Google Trends and Amazon bestseller rankings during the Black Friday period, strong sales in North America can be expected in the fourth quarter."
APR's brand 'MediCube' has surpassed domestic indie brands 'COSRX' and 'Joseon Minyeo' in Google search trend indicators since last month. Its flagship product, Booster Pro, maintains the number one position in the wrinkle and anti-aging device category.
Operating profit this year is expected to increase by 17% to 122 billion KRW compared to last year (104.2 billion KRW), and next year's operating profit is projected to grow by 32% to 160.8 billion KRW compared to this year.
Jonghyun Park, a researcher at Daol Investment & Securities, said, "In the short term, expansion of B2B retailer contracts in key countries and penetration into non-core countries are expected," adding, "In the mid to long term, we anticipate APR to become a leading anti-aging stock through the expansion of its medical device business."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![[Featured Stock] Strong North American Sales Boost APR Shares by Over 5%](https://cphoto.asiae.co.kr/listimglink/1/2024072208164559128_1721603806.jpg)

